Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.467EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.74 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.623EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.588EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.567EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.541EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.563EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.399EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.539EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.392EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used